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Abstract
Background: There are not enough data on the epidemiology of asthma in the Kingdom of Saudi Arabia (KSA). We
analyzed data from a national household survey conducted in KSA in 2013 to estimate prevalence, associated risk
factors and control measurements of asthma.
Methods: The Saudi Health Interview Survey was a cross-sectional national multistage survey of 10,735 individuals
aged 15 years or older. The survey included a detailed household questionnaire and a physical exam. We used
self-reported clinical diagnosis of asthma to assess prevalence of asthma.
Results: The prevalence of asthma in KSA was 4.05 % (95 % confidence interval [CI]: 3.54–4.62 %). Asthma was less
frequent in individuals with higher education but higher in former smokers and obese individuals. Around 76.7 % of
asthma patients (95 % CI: 70.6–82.0 %) experienced an asthmatic attack, and 61.6 % (95 % CI: 54.4–68.4 %) visited a
hospital/emergency room because of asthma during the past year. Asthma attack was less frequent in older
patients (odds ratio [OR] = 0.78, 95 %CI: 0.59–0.96 for each decade of life). Current use of medication for
asthma was highly associated with asthma attacks (OR = 9.14, 95 % CI: 3.29–25.38). Asthma attack was also
more frequent in individuals who were exposed to secondhand smoking (OR = 2.17, 95 %CI: 1.05–4.45) and
those who were obese (OR = 3.01, 95 %CI: 1.34–6.78).
Conclusion: Saudi Arabia has a relatively low prevalence of diagnosed asthma; however, many of the patients with
known asthma do not have it under good control. Our study calls for programs to inform patients about the
importance and proper means of controlling their condition. Implementing and monitoring of clinical guidelines can
also help to improve asthma control among patients as well as identify undiagnosed cases.
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Background
Asthma is a major health issue worldwide. It is among
the top 30 highest-burden diseases based on the Global
Burden of Disease 2010 study (GBD 2010) [1].
In the Kingdom of Saudi Arabia (KSA), asthma ranks
19th in terms of disability-adjusted life years (DALYs)
and 26th in deaths [1, 2]. There are reports on its in-
creasing pattern in KSA [3].
Few epidemiological studies exist on asthma in KSA.
The Saudi initiative for asthma (2012) stated that the
prevalence of asthma in Saudi adults is unknown, and
the overall prevalence in Saudi children ranges from 8 to
25 % in different studies [4].
Al-Frayh reported an increase in the prevalence of
asthma from 8 % in 1986 in Jeddah and Riyadh (costal
humid and desert dry, respectively) to 23 % in 1995 in
Jizan and Hail (costal humid and desert dry, respectively)
among schoolchildren aged 6 to 18 years. He also re-
ported in another study a prevalence of 33.7 % in Hofuf
(inland eastern), 17.7 % in Riyadh (inland central), and
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14.1 % in Jaddah (western coastal) in 2002 among
schoolchildren [3, 5, 6]. Hijazi (1998) reported a prevalence
of 12.1 % among children aged 12 years in Jaddeh [7].
Prevalence of bronchial asthma was reported to be
14 % in individuals aged 11 years or older in rural areas
of the Asir region [8]. Al-Ghobian reported a prevalence
of 19.6 % for physician-diagnosed asthma among stu-
dents aged 16 to18 in Riyadh during the 2009–2010 aca-
demic year [9].
KSA provides free health care to all citizens. There-
fore, it is crucial to have accurate and updated health in-
formation for planning. To estimate the prevalence,
associated risk factors and control measurements of
asthma in Saudi adults, we analyzed data from a national
household survey conducted in 2013.
Methods
The Saudi Health Interview Survey was a cross-sectional
national multistage survey of adult Saudi citizens. Adult-
hood in KSA is defined as 15 years of age or older. KSA
had a population of 26.9 million in 2013, with 5.6 million
non-nationals. The sample size was designed to ensure a
confidence level of 95 %, with a margin of error of 0.05
and a baseline level of indicators of 0.5. A previous na-
tional study conducted by MOH yielded a design effect of
1.5 and a response rate of 85 %. Adjusting for the design
effect and response rate, a sample size of 11,806 was se-
lected and rounded to 12,000. The whole country was di-
vided into 13 regions, and each region was divided into
subregions and blocks. All regions were included, and a
probability proportional to size method was used to ran-
domly select subregions and blocks. Households were ran-
domly selected from each block. A roster of household
members was conducted and an adult aged 15 or older
was randomly selected from the household to be surveyed.
If the randomly selected adult was not present, our sur-
veyors made another appointment to return, up to three
times, before considering the household as a nonresponse.
The Saudi Ministry of Health and its Institutional
Review Board (IRB) approved the study protocol. The
University of Washington IRB deemed the study as
IRB-exempt, since the Institute for Health Metrics
and Evaluation received de-identified data for this
analysis. Only those individuals who agreed to partici-
pate and consented after receiving all required infor-
mation about the survey were entered into the study.
The survey included questions for socio-demographic
characteristics, self-report of clinician-diagnosed asthma and
other chronic diseases, risk factors and functional status.
Individuals were classified into three groups—never
smokers, former smokers and current smokers—through
two questions: “Have you ever smoked any tobacco
products, such as cigarettes, cigars or pipes or Shisha?”
and “Do you currently smoke any tobacco products,
such as cigarettes, cigars, pipes or Shisha?” To assess ex-
posure to secondhand smoke, respondents were asked,
“During the past 7 days, on how many days did someone
in your home smoke when you were present?” and “During
the past 7 days, on how many days did someone smoke in
closed areas in your workplace or school (in the building,
in a work area or a specific office) when you were present?”
Those who reported such exposure for at least one
day either at home or in their workplace were classi-
fied as exposed to secondhand smoke.
Weight, height and blood pressure were measured at
the household by a trained professional through standard
methods. We used measured weight and height to calcu-
late body mass index (BMI) as kg/m2. Participants were
classified into four groups: underweight (BMI < 18.5), nor-
mal weight (18.5 ≤ BMI < 25), overweight (25 ≤ BMI < 30),
and obese (BMI ≥ 30).
Respondents were also asked, “Does your health now
limit you in doing vigorous activities, such as running, lift-
ing heavy objects, or participating in strenuous sports?”
To assess clinician-diagnosed asthma, respondents
were asked, “Has a doctor or other health professional
ever told you that you had asthma, otherwise known as
reactive airway disease?” Similar questions were asked
for chronic obstructive pulmonary disease (COPD), con-
gestive heart failure (CHF) and type 1 diabetes mellitus.
Participants were asked, “During the past 30 days, have
you had wheezing or whistling in your chest?” and “Did
you cough on most days for 3 consecutive months or
more during the past year?” as important symptoms of
respiratory diseases; we did not use these questions as
alternative for diagnosis of respiratory diseases.
Those who reported a diagnosis of asthma were asked
about treatment (“During the past 30 days, or since your
diagnosis, have you ever taken medication for this condi-
tion?”), asthma attack (“During the last 12 months did
you have an attack of asthma?”), worsening of symptoms
(“During the past 12 months, has your asthma gotten
worse?”), and visiting a hospital, or emergency room be-
cause of worsening asthma symptoms (“During the past
12 months, how many times have you visited the hos-
pital or emergency room because of worsening asthma
symptoms?”).
In all analyses, 95 % was used as the level of signifi-
cance. We used a backward elimination multivariate lo-
gistic regression model to measure association between
the outcome variables of asthma and different factors,
including sex, age, education, smoking, secondhand
smoke exposure, BMI, type 1 diabetes and hypertension.
All independent variables were first included in the
model. Then variables were removed based on a Wald
chi-square test for analysis of effect; variables were re-
moved one by one based on the significance level of
their effect on the model, starting with the variable with
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the highest p > 0.5, until all variables kept had a p ≤ 0.5
for at least one of their subcategories in the final model.
Of the 10,735 completed interviews, there were 74
missing values for asthma, 310 missing values for limited
vigorous activity, 115 missing values for diagnosed dia-
betes status, 29 missing values for smoking status, 1572
missing values for secondhand smoking exposure, 398
missing BMI values, 33 missing marital status values,
and 20 missing educational level values. We excluded
missing variables from our analyses.
We used Stata 13.1 for Windows (StataCorp LP, TX,
USA) for the analyses and to account for the complex
sampling design.
Results
A total of 12,000 households were originally contacted,
and 10,735 participants completed the Saudi Health
Interview Survey between April and June 2013 (response
rate: 89.4 %). Prevalence of asthma was 4.05 % (95 % CI:
3.54–4.62 %); we estimated there are 525,794 Saudis
aged 15 years or older with asthma in KSA. Figure 1
shows the prevalence of asthma by sex and age groups.
There was a slightly increasing trend from the third dec-
ade of life in both sexes. However, the prevalence was not
statistically significant between age-sex subgroups. Preva-
lence of asthma varied slightly by KSA regions (Fig. 2).
A logistic regression model was used to assess associ-
ation of different socio-demographic and health factors
with asthma (p < 0.001). Individuals with college or
higher education were less likely to have asthma than in-
dividuals with primary education or less. Asthma was as-
sociated with being a former smoker (Table 1).
About 15.5 % (95 % confidence interval [CI]: 10.7–21.6)
of individuals with asthma reported that they had not
taken any medication for asthma at all; 49.4 % (95 % CI:
42.4–56.4 %) were under treatment at the time of survey,
and 35.3 % (95 % CI: 28.9–42.1 %) reported taking medi-
cation previously, but not at the time of the survey.
Around 76.7 % of individuals with asthma (95 % CI:
70.6–82.0 %) had experienced an asthma attack during
the last 12 months, and 31.2 % (95 % CI: 27.4–38.4 %)
believed that their asthma had gotten worse in the past
12 months. Logistic regression models were used to find
associated factors with asthma attacks and emergency
room/hospital visits. Both models were statistically sig-
nificant (p < 0.001). Asthma attack was less frequent in
older patients. Current use of medication for asthma
was highly associated with asthma attacks (odds ratio
[OR] = 9.14, 95 % CI: 3.29–25.38). Asthma attack was
also more frequent in individuals who were exposed to
secondhand smoke (Table 2).
During the past 12 months, 61.6 % (95 % CI:
54.4–68.4 %) had visited a hospital or emergency
room because of worsening asthma symptoms. That
was less likely for individuals with higher education
and former smokers (Table 2). About 72 % (95 % CI:
63.5–78.9 %) who had an asthma attack were re-
ferred to a hospital or emergency room. Those with
asthma were more likely to miss days of work com-
pared to those without (3.8 vs. 2.6 days in the past
year, P = 0.024).
Those with asthma were more likely to report wheez-
ing or whistling in the chest during the last 30 days
compared to others, 58.5 % (95 % CI: 51.4–62.3 %) and
3.7 % (95 % CI: 3.2–4.2 %), respectively. Furthermore,
they were more likely to report cough on most days for
three consecutive months or during the past year (9.8 %
vs. 1.9 %), limitations for vigorous physical activity
(55.3 % vs. 34.1 %), COPD (1.7 % vs. 0.13 %), and con-
gestive heart failure (1.8 % vs 0.25 %). The associations
between asthma and vigorous physical activity, COPD and
congestive heart failure remained significant after adjust-
ment of socio-demographic factors, BMI and smoking in
statistically significant logistic regression models (Table 3).
Discussion
Our study revealed relatively low prevalence of asthma
in the Kingdom of Saudi Arabia. Our findings showed
that those diagnosed with asthma in KSA do not have
good control over their condition; incidence of asthma
attacks and referral to hospitals for asthma management
were considerably high. Moreover, our data showed that
many of these individuals do not take appropriate med-
ical care in order to control their asthma. This finding is
of great importance as medical care is free in KSA.
The KSA Ministry of Health launched several programs
to improve asthma awareness. The Asthma Insights and
Reality in the Kingdom of Saudi Arabia (AIRKSA) was
launched in 2008 to assess the level of asthma control
among asthmatics [10]. Another asthma initiative was
Fig. 1 Prevalence (and 95 % confidence intervals) of asthma by sex
and age group, Saudi Arabia, 2013
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launched in 2009 to promote best practices in asthma
management [4]. Although it is too early to tell the impact
of these programs, clearly there is a need for a compre-
hensive program for early diagnosis and appropriate man-
agement of asthma for children and adults. Indeed, good
management of asthma has a positive impact on quality of
life of patients [11].
Our study showed that 62 % of asthma patients re-
ported an emergency room visit, which was very close to
the 65 % reported by AIRKSA. The numbers are not dir-
ectly comparable, but the fact that they are close, and
very high, calls for immediate attention to asthma in
KSA. The annual rate of emergency room visits by
people with asthma in European countries is around
11 % [10]. This points to a lack of control of asthma in
KSA, which creates a demand for emergency care. This
is not sustainable, and programs to reverse this trend are
urgently needed.
There are very few studies on the prevalence of
asthma in adults in the countries of the region. Esti-
mates are available for physician-diagnosed asthma in
Turkey, from 5.1 to 6.2 % in urban areas and from 3.5 to
10.8 % in rural areas [12, 13]. Mohammad reported
asthma in 13.1 % of individuals visiting primary health
care facilities, outpatient facilities, or emergency depart-
ments in Syria [14]. Mahboub reported an asthma preva-
lence of 12.1 % (95 % CI: 10.4–14.1 %) for all ages in the
United Arab Emirates based on European Community
Respiratory Health Survey screening criteria [15].
Our study has some limitations. First, our data are
cross-sectional and hence we cannot assess causality.
Second, many of our behavioral data, such as those re-
lated to smoking, are self-reported and subject to recall
and social desirability biases. Third, in this study, we re-
port cases of self-reported diagnosed asthma. Milder
cases are more likely to be undiagnosed or not reported
by the participants. This might be related to high fre-
quency of asthmatic attacks and referral to hospitals in
our cases. Fourth, our survey did not collect information
on family history of asthma or personal history of aller-
gic rhinitis or hay fever. However, our study is based on
a large national sample with rigorous data-collection
methods and near-real-time data quality monitoring
through the whole survey period.
It is not clear why many patients in Saudi Arabia do
not receive proper treatment when health care and
Fig. 2 Prevalence range of asthma in different regions of Saudi Arabia, 2013
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medications are free for Saudi nationals. There is an ur-
gency to reduce the financial and human burden of pre-
ventable and controllable diseases and risk factors in
KSA. Patient education is needed to reduce the burden
of asthma in KSA. The primary focus should be on indi-
viduals with asthma (and their families) for improving
the quality of disease management [16]. Moreover, a na-
tional plan to inform the general public about the im-
portance of early diagnosis and management of asthma
is needed. We have previously shown that Saudis do not
seek preventive care; [17] therefore these programs
should be promoted as generally increasing Saudis’
health, not as specific preventive activities. Also, there
are specific instructions to reduce allergic asthma and
occupational asthma through avoiding or reducing ex-
posure to allergens [16, 18–20]. Finally, programs to
educate physicians and medical assistants about appro-
priate ways to message the importance of preventive
care and adequate follow-up for asthma are needed.
Since different studies have emphasized low adherence
by health care providers to clinical guidelines for asthma
in KSA, new programs should include methods for im-
proving this adherence [4, 21, 22].
Our finding of high rates of asthma among former
smokers deserves further attention. Indeed, in a cross-
sectional study, we cannot detect temporality of getting
asthma and quitting smoking, but the fact that the rela-
tionship of asthma with former smoking is stronger than
with current smoking has been shown in other studies
as well. Some individuals stop smoking because of the
onset of respiratory symptoms and are later diagnosed
with asthma, and some individuals quit smoking because
of diagnosed asthma [23–25]. The association of smok-
ing and asthma is strong and well documented [11, 25].
On the other hand, we pooled all current smokers with-
out considering their history of smoking over time,
which might influence the analysis results. Other find-
ings of our survey revealed an increasing trend in
cigarette smoking among men and shisha smoking
among men and women in KSA [26]. Therefore, smok-
ing prevention programs should be strengthened in KSA
in order to reduce the burden of all diseases caused or
aggravated by tobacco products (including asthma).
Based on our data, exposure to secondhand smoking
was associated with asthma attacks, which underscores
the importance of tobacco-free settings.
Table 1 The prevalence of asthma in relation to socio-demographic and health characteristics in Saudi adults, 2013
Factor Categories Total number
(Weighted %)
Prevalence pa AOR 95 % CI
Cases (Percent) SE
Sex Male 5224 (50.71) 210 (4.53) 0.42 0.08 Ref -
Female 5437 (49.29) 180 (3.56) 0.38 0.79 0.57–1.08
Education Primary or less 3251 (26.27) 150 (5.23) 0.61 0.03 Ref -
Elementary/high 4755 (51.92) 149 (3.76) 0.40 0.72 0.52–1.01
College or higher 2637 (21.80) 91 (3.40) 0.47 0.59 0.39–0.87
Smoking status Never smoker 8837 (84.06) 315 (3.90) 0.30 0.04 Ref -
Former smoker 453 (3.733) 29 (7.47) 1.75 2.01 1.14–3.55
Current smoker 1347 (12.21) 44 (4.13) 0.80 1.04 0.65–1.66
Secondhand smoking Unexposed 7048 (76.75) 260 (4.16) 0.36 0.84 Ref -
Exposed 2122 (23.25) 93 (4.61) 0.65 NA -
Body mass index (kg/m2) 18.5–24.9 (Normal) 2973 (32.72) 77 (2.81) 0.41 <0.001 Ref -
<18.5 (Underweight) 447 (6.505) 18 (5.88) 1.59 2.00 1.03–3.88
25–29.9 (Overweight) 3431 (29.72) 114 (3.11) 0.41 1.06 0.69–1.63
30 or more (Obese) 3810 (31.05) 179 (5.90) 0.60 1.98 1.33–2.95
Type 1 diabetes No 10,422 (98.87) 62 (6.66) 1.09 0.002 Ref -
Yes 150 (1.129) 328 (3.85) 0.29 0.35 0.08–1.49
Blood pressure Normal 4767 (49.58) 161 (3.79) 0.40 0.04 Ref -
Pre-hypertension 3663 (31.54) 126 (3.66) 0.45 0.87 0.61–1.24
Stage I hypertension 1196 (8.933) 65 (6.52) 1.18 1.37 0.85–2.23
Stage II hypertension 1035 (9.951) 38 (4.43) 0.94 1.23 0.72–2.09
Age was removed during the backward elimination (p > 0.5)
SE standard error, AOR adjusted odds ratio, NA not applicable because the subgroup was removed from the model during the backward elimination, Ref
reference group
ap for chi2 unadjusted tests
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Table 3 Association of limited vigorous activity, chronic obstructive pulmonary disease and congestive heart failure with asthma,
KSA, 2013
Factors Categories Model 1 Model 2 Model 3 Model 4
AOR 95 % CI AOR 95 % CI AOR 95 % CI AOR 95 % CI
Age (decades) 0.90 0.79–1.03 NA - NA - 0.88 0.77–1.01
Sex Male Ref - Ref - Ref - -
Female 0.68 0.49–0.95 0.78 0.56–1.08 0.78 0.56–1.08 0.68 0.48–0.95
Education Primary or less Ref - Ref - Ref - -
Elementary/high 0.77 0.52–1.12 0.72 0.51–1.01 0.7 0.5–0.98 0.74 0.50–1.09
College or higher 0.65 0.42–1.01 0.6 0.4–0.91 0.6 0.4–0.9 0.66 0.42–1.02
Limited vigorous activity No Ref - NI - NI - -
Yes 2.60 1.78–3.79 NI - NI - 2.48 1.69–3.62
Chronic obstructive pulmonary disease No NI - Ref - NI - -
Yes NI - 11.38 4.33–29.93 NI - 9.53 2.90–31.35
Congestive heart failure No NI - NI - Ref - -
Yes NI - NI - 5.07 1.52–16.86 2.70 0.63–11.55
Smoking status Never smoker Ref - Ref - Ref - -
Former smoker 1.94 1.09–3.43 2.01 1.14–3.54 2.06 1.17–3.61 1.97 1.10–3.53
Current smoker 1.05 0.66–1.69 1.05 0.65–1.69 1.05 0.65–1.69 1.05 0.64–1.7
Body mass index (kg/m2) 18.5–24.9, Normal Ref - - - -
<18.5, Underweight 1.98 1–3.92 2.02 1.02–3.99 2.12 1.1–4.11 2.07 1.04–4.1
25–29.9, Overweight 1.09 0.70–1.70 1.07 0.69–1.66 1.12 0.73–1.73 1.16 0.74–1.81
30 or more, Obese 2.01 1.34–3.03 2.09 1.42–3.08 2.14 1.45–3.15 2.13 1.41–3.22
AOR adjusted odds ratio, NA dropped from the model during the backward elimination, NI not included in the model, Ref reference group
Table 2 Factors associated with asthma attack and visiting an emergency room/hospital because of asthma during the past
12 months in individuals with asthma, Saudi Arabia, 2013
Factor Categories Asthma attack Visit to ER/hospital
AOR 95 % CI AOR 95 % CI
Age (decade) 0.76 0.59–0.96 NA -
Sex Male Ref - Ref -
Female 0.77 0.36–1.63 NA -
Education Primary or less Ref - Ref -
Elementary/high 0.66 0.25–1.75 0.45 0.22–0.96
College or higher 0.37 0.14–1.02 0.26 0.11–0.62
Medication for asthma Never used Ref - Ref -
Current use 9.14 3.29–25.38 2.53 1.01–6.34
Previous use 1.74 0.71–4.25 0.64 0.24–1.70
Smoking status Never smoker Ref - Ref -
Former smoker 0.52 0.17–1.61 0.39 0.15–0.97
Current smoker NA - NA -
Secondhand smoke exposure Unexposed Ref - Ref -
Exposed 2.17 1.05–4.45 1.37 0.62–2.99
Body mass index (kg/m2) 18.5–24.9, Normal Ref - Ref -
<18.5, Underweight NA - 3.95 0.83–18.92
25–29.9, Overweight 2.28 0.84–6.18 NA -
30 or more, Obese 3.01 1.34–6.78 NA -
AOR adjusted odds ratio, NA dropped from the model during the backward elimination, Ref reference group
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There is no consensus on the association of asthma
with a desert environment. Some studies did not find a
relationship between sand storms and asthma prevalence
or aggravation, while others consider these storms im-
portant risk factors for chronic respiratory disease and
severity of asthma [27, 28]. Based on the report of the
Global Initiative for Asthma (GINA) Program, Tunisia,
Ethiopia and Algeria, from a relatively close geographical
region to KSA, are among the countries with the lowest
prevalence of current symptoms of asthma in adults (all less
than 5 %), while some of the high-income Commonwealth
countries, such as Wales, Australia, Scotland, Republic of
Ireland and Canada, have the highest prevalence estimates
(all more than 25 %) [29]. In this study, we did not observe
noticeable differences in the prevalence of asthma between
different official governmental regions of KSA.
Conclusion
Saudi Arabia has a relatively low prevalence of diagnosed
asthma; however, many of the patients with known
asthma are not under good control. Our study calls for
programs to inform patients about the importance and
proper means to control their condition. Moreover, our
study calls for programs to educate the Saudi public
about the importance of preventive strategies, early diag-
nosis and proper management of asthma.
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